Annovis Bio announces special shareholder meeting
- Annovis Bio will hold a special shareholder meeting in a telephonic virtual format on Oct. 14, 2026.
- Shareholders will vote on increasing authorized common shares to 140,000,000 from 70,000,000.
- The meeting will also consider increasing authorized preferred shares to 10,000,000 from 2,000,000.
- Investors will vote to ratify an amended 2019 equity incentive plan, lifting the share reserve to 5,500,000.
- A separate proposal seeks approval to adjourn the meeting if needed to solicit additional proxies.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Annovis Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-107113), on September 11, 2026, and is solely responsible for the information contained therein.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Trade now！
You may also like
Crypto prices
More
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now